Literature DB >> 6525996

A carcinogenic potency database of the standardized results of animal bioassays.

L S Gold, C B Sawyer, R Magaw, G M Backman, M de Veciana, R Levinson, N K Hooper, W R Havender, L Bernstein, R Peto.   

Abstract

The preceding paper described our numerical index of carcinogenic potency, the TD50 and the statistical procedures adopted for estimating it from experimental data. This paper presents the Carcinogenic Potency Database, which includes results of about 3000 long-term, chronic experiments of 770 test compounds. Part II is a discussion of the sources of our data, the rationale for the inclusion of particular experiments and particular target sites, and the conventions adopted in summarizing the literature. Part III is a guide to the plot of results presented in Part IV. A number of appendices are provided to facilitate use of the database. The plot includes information about chronic cancer tests in mammals, such as dose and other aspects of experimental protocol, histopathology and tumor incidence, TD50 and its statistical significance, dose response, author's opinion and literature reference. The plot readily permits comparisons of carcinogenic potency and many other aspects of cancer tests; it also provides quantitative information about negative tests. The range of carcinogenic potency is over 10 million-fold.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6525996      PMCID: PMC1569423          DOI: 10.1289/ehp.84589

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  425 in total

1.  Life-term effects of mercury, methyl mercury, and nine other trace metals on mice.

Authors:  H A Schroeder; M Mitchener
Journal:  J Nutr       Date:  1975-04       Impact factor: 4.798

2.  Carcinogenicity of 5-nitrofurans and related compounds with amino-heterocyclic substituents.

Authors:  S Cohen; E Ertürk; A Von Esch; A Corvetti; G Bryan
Journal:  J Natl Cancer Inst       Date:  1975-04       Impact factor: 13.506

3.  Chronic oral toxicity and related studies on animals with the insecticide and pyrethrum synergist, piperonyl butoxide.

Authors:  M P SARLES; W B VANDEGRIFT
Journal:  Am J Trop Med Hyg       Date:  1952-09       Impact factor: 2.345

4.  Carcinogenic effects of low dietary levels of aflatoxin B1 in rats.

Authors:  G N Wogan; S Paglialunga; P M Newberne
Journal:  Food Cosmet Toxicol       Date:  1974-10

5.  Nodular hyperplasia in the rat liver following prolonged feeding of Ponceau MX.

Authors:  P Grasso; A B Lansdown; I S Kiss; I F Gaunt; S D Gangolli
Journal:  Food Cosmet Toxicol       Date:  1969-09

6.  Carcinogenesis in the esophagus. II. Experimental production of esophageal cancer by administration of ethanolic solution of carcinogens.

Authors:  A Horie; S Hohchi; M Kuratsune
Journal:  Gan       Date:  1965-10

7.  CArcinogenic activity of clivorine, a pyrrolizidine alkaloid isolated from Ligularia dentata.

Authors:  K Kuhara; H Takanashi; I Hirono; T Furuya; Y Asada
Journal:  Cancer Lett       Date:  1980-08       Impact factor: 8.679

8.  Comparative carcinogenicity in Swiss mice of N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide and structurally related 5-nitrofurans and 4-nitrobenzenes.

Authors:  S M Cohen; G M Lower; E Ertürk; G T Bryan
Journal:  Cancer Res       Date:  1973-07       Impact factor: 12.701

9.  Development of hepatocellular carcinomas in rats treated with benzene hexachloride.

Authors:  N Ito; H Nagasaki; H Aoe; S Sugihara; Y Miyata
Journal:  J Natl Cancer Inst       Date:  1975-03       Impact factor: 13.506

10.  Induction of tumors in mice with the herbicide succinic acid 2,2-dimethylhydrazide.

Authors:  B Toth; L Wallcave; K Patil; I Schmeltz; D Hoffmann
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

View more
  58 in total

1.  Dietary pesticides (99.99% all natural).

Authors:  B N Ames; M Profet; L S Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 2.  Dietary carcinogens, environmental pollution, and cancer: some misconceptions.

Authors:  B N Ames; L S Gold
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

3.  Global structure-activity relationship model for nonmutagenic carcinogens using virtual ligand-protein interactions as model descriptors.

Authors:  Albert R Cunningham; C Alex Carrasquer; Shahid Qamar; Jon M Maguire; Suzanne L Cunningham; John O Trent
Journal:  Carcinogenesis       Date:  2012-06-07       Impact factor: 4.944

4.  Comparison of in vitro and in vivo clastogenic potency based on benchmark dose analysis of flow cytometric micronucleus data.

Authors:  Jeffrey C Bemis; John W Wills; Steven M Bryce; Dorothea K Torous; Stephen D Dertinger; Wout Slob
Journal:  Mutagenesis       Date:  2015-06-06       Impact factor: 3.000

5.  Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogens.

Authors:  W K Lutz
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

6.  Rodent carcinogens in human food: are they important?

Authors:  K E von Mühlendahl
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

Review 7.  DNA adducts in experimental cancer research.

Authors:  K Hemminki; A Försti; R Mustonen; K Savela
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

8.  Chemical structure determines target organ carcinogenesis in rats.

Authors:  C A Carrasquer; N Malik; G States; S Qamar; S L Cunningham; A R Cunningham
Journal:  SAR QSAR Environ Res       Date:  2012-10-16       Impact factor: 3.000

9.  Possible implications from results of animal studies in human risk estimations for benzene: nonlinear dose-response relationship due to saturation of metabolism.

Authors:  S Grilli; W K Lutz; S Parodi
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

10.  Physiochemical property space distribution among human metabolites, drugs and toxins.

Authors:  Varun Khanna; Shoba Ranganathan
Journal:  BMC Bioinformatics       Date:  2009-12-03       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.